共 97 条
- [1] Boeckh M(1996)Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study Blood 88 4063-4071
- [2] Gooley TA(2001)Rising p65 antigenemia during pre-emptive anti cytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes Blood 97 867-874
- [3] Myerson D(2005)Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients Haematologica 90 526-533
- [4] Cunningham T(2001)Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin Blood 97 3676-3677
- [5] Schoch G(2005)Human cytomegalovirus resistance to antiviral drugs Antimicrob Agents Chemother 49 873-883
- [6] Bowden RA(1998)Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection J Clin Microbiol 36 1113-1116
- [7] Nichols WG(2003) model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant patients J Infect Dis 188 1639-1647
- [8] Corey L(2008)Enumeration of CMV-specific IFNγ CD8 Haematologica 93 1434-1436
- [9] Gooley T(2001) and CD4 J Clin Microbiol 39 3938-3941
- [10] Drew WL(2008) T cells early after allogeneic stem cell transplantation may identify patients at risk of active CMV infection J Clin Microbiol 46 3311-3318